Anti-GD2 Strategy in the Treatment of Neuroblastoma

Por Yang, Richard K., Sondel, Paul M.
Publicado em 2010

Intratumoral delivery of low doses of anti-CD40 mAb combined with monophosphoryl lipid A induces local and systemic antitumor effects in immunocompetent and T cell-deficient mice

Por Van De Voort, Tyler J., Felder, Mildred A. R., Yang, Richard K., Sondel, Paul M., Rakhmilevich, Alexander L.
Publicado em 2013

Quantification of Tetracycline Resistance Genes in Feedlot Lagoons by Real-Time PCR

Por Smith, Marilyn S., Yang, Richard K., Knapp, Charles W., Niu, Yafen, Peak, Nicholas, Hanfelt, Margery M., Galland, John C., Graham, David W.
Publicado em 2004

Soluble Interleukin-2 Receptor α Activation in a Children’s Oncology Group Randomized Trial of Interleukin-2 Therapy for Pediatric Acute Myeloid Leukemia

Por Lange, Beverly J., Yang, Richard K., Gan, Jacek, Hank, Jaquelyn A., Sievers, Eric L., Alonzo, Todd A., Gerbing, Robert B., Sondel, Paul M.
Publicado em 2011

Correlations between in situ denitrification activity and nir-gene abundances in pristine and impacted prairie streams

Por Graham, David W., Trippett, Clare, Dodds, Walter K., O’Brien, Jonathan M., Banner, Eric B.K., Head, Ian M., Smith, Marilyn S., Yang, Richard K., Knapp, Charles W.
Publicado em 2010

Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effects

Por Rakhmilevich, Alexander L., Baldeshwiler, Mark J., Van De Voort, Tyler J., Felder, Mildred A. R., Yang, Richard K., Kalogriopoulos, Nicholas A., Koslov, David S., Van Rooijen, Nico, Sondel, Paul M.
Publicado em 2012

Intratumoral hu14.18–IL-2 (IC) Induces Local and Systemic Antitumor Effects That Involve Both Activated T and NK Cells As Well As Enhanced IC Retention

Por Yang, Richard K., Kalogriopoulos, Nicholas A., Rakhmilevich, Alexander L., Ranheim, Erik A., Seo, Songwon, Kim, KyungMann, Alderson, Kory L., Gan, Jacek, Reisfeld, Ralph A., Gillies, Stephen D., Hank, Jacquelyn A., Sondel, Paul M.
Publicado em 2012

Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the Hu14.18 antibody increases intratumoral CD8+ T and NK cells...

Por Yang, Richard K., Kalogriopoulos, Nicholas A., Rakhmilevich, Alexander L., Ranheim, Erik A., Seo, Songwon, Kim, KyungMann, Alderson, Kory L., Gan, Jacek, Reisfeld, Ralph A., Gillies, Stephen D., Hank, Jacquelyn A., Sondel, Paul M.
Publicado em 2013

The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model

Por Soto, Brenda L., Hank, Jacquelyn A., Van De Voort, Tyler J., Subramanian, Lalita, Polans, Arthur S., Rakhmilevich, Alexander L., Yang, Richard K., Seo, Songwong, Kim, KyungMann, Reisfeld, Ralph A., Gillies, Stephen D., Sondel, Paul M.
Publicado em 2011

In situ tumor vaccination by combining local radiation and tumor-specific antibody or immunocytokine treatments

Por Morris, Zachary S., Guy, Emily I., Francis, David M., Gressett, Monica M., Werner, Lauren R., Carmichael, Lakeesha L., Yang, Richard K., Armstrong, Eric A., Huang, Shyhmin, Navid, Fariba, Gillies, Stephen D., Korman, Alan, Hank, Jacquelyn A., Rakhmilevich, Alexander L., Harari, Paul M., Sondel, Paul M.
Publicado no Cancer Res (2016)